Kissei America

Kissei America is the United States subsidiary of Kissei Pharmaceutical Co., Ltd., a Japanese pharmaceutical company dedicated to the development and commercialization of innovative medicines. The company focuses on therapeutic areas including urology, nephrology, dialysis, and rare diseases, managing clinical development and regulatory strategies for the North American market. Kissei America plays a critical role in advancing the parent company's pipeline through strategic partnerships and licensing agreements, notably contributing to the availability of treatments for ANCA-associated vasculitis and urological disorders. Their business model emphasizes bridging Japanese innovation with global clinical standards to address unmet medical needs.